• Users Online: 5091
  • Home
  • Print this page
  • Email this page

   Table of Contents      
Year : 2013  |  Volume : 61  |  Issue : 8  |  Page : 428-429

Current status of accelerated corneal cross-linking

IROC Innocross AG, Technoparkstrasse 1, Zurich, Switzerland

Date of Submission16-Jul-2013
Date of Acceptance22-Jul-2013
Date of Web Publication3-Aug-2013

Correspondence Address:
Michael Mrochen
PhD, IROC Innocross AG, Zurich, Switzerland

Login to access the Email id

Source of Support: None, Conflict of Interest: Shareholder of IROC Innocross AG.

DOI: 10.4103/0301-4738.116075

Rights and Permissions

Corneal cross-linking with riboflavin is a technique to stabilize or reduce corneal ectasia, in diseases such as keratoconus and post-laser-assisted in situ keratomileusis (LASIK) ectasia. There is an interest by patient as well as clinicians to reduce the overall treatment time. Especially, the introduction of corneal cross-linking in combination with corneal laser surgery demands a shorter treatment time to assure a sufficient patient flow. The principles and techniques of accelerated corneal cross-linking is discussed.

Keywords: Accelerated corneal cross linking, keratoconus, corneal laser surgery, corneal ectasia, UV light, riboflavin

How to cite this article:
Mrochen M. Current status of accelerated corneal cross-linking. Indian J Ophthalmol 2013;61:428-9

How to cite this URL:
Mrochen M. Current status of accelerated corneal cross-linking. Indian J Ophthalmol [serial online] 2013 [cited 2022 Aug 15];61:428-9. Available from: https://www.ijo.in/text.asp?2013/61/8/428/116075

Corneal cross-linking with riboflavin is a technique to stabilize or reduce corneal ectasia, in diseases such as keratoconus and post- laser-assisted in situ keratomileusis (LASIK) ectasia. Corneal cross-linking has been demonstrated to improve corneal strength by creating additional bonds within the corneal tissue in in vitro investigations and to stop the progression of the ectasia in clinical trials. The standard corneal cross-linking treatment uses a 30-min instillation of drops (0.1% riboflavin in 20% dextran), followed by 30 min of 365 nm ultraviolet-A (UV-A) illumination at 3 mW/cm 2 for 30 min (5.4 J/cm 2 dose). This procedure has been found to reduce corneal curvature greater than 1-1.5 D after treatment, with improvement persisting for 5 or more years. [1]

There is an interest by patient as well as clinicians to reduce the overall treatment time. Especially, the introduction of corneal cross-linking in combination with corneal laser surgery demands a shorter treatment time to assure a sufficient patient flow. Therefore, a reduction of the illumination time to a few minutes or even to several seconds has to provide sufficient efficacy.

There are attempts to shorten the illumination time by increasing the illumination intensity. Here, it is assumed that the Bunsen-Roscoe law of reciprocity is valid for the corneal cross-linking effect, having a constant radiant exposure of 5.4 J/cm 2 . It has been shown in ex vivo experiments that the biomechanical stiffening effect of the corneal tissue is equivalent with 10 mW/cm 2 (illumination time 9 min) to the standard protocol. [2] However, more recently Wernli et al., [3] determined the efficacy of corneal cross-linking for higher intensities, the change in corneal stiffness that is evoked by the cross-linking treatment of ex vivo porcine corneal tissue. As samples for the biomechanical measurements, one test strip was cut out of each cornea, which was randomly assigned to one of the groups with different treatment intensities. The intensities varied from 3-90 mW/cm 2 , with a constant energy dose of 5.4 J/cm 2 and corresponding illumination times ranging from 30 to 1 min. To each of these groups, control eyes of the same date were tested, which were not irradiated with UV light, but otherwise underwent the same procedure including a soaking with riboflavin solution.

It is known from photography that the Bunsen-Roscoe law is only valid for a certain range and so far, it is not known how large this range is for corneal cross-linking. This means that the corneal cross-linking effect may be dependent on a threshold and the increase in illumination intensity (decrease in illumination time) is limited. As a fact, the data presented by Wernli et al.[3] shows the dependence of increase in corneal stiffness on illumination intensity while keeping a constant irradiation dose of 5.4 J/cm 2 . An equivalent stiffness increase can be achieved up to an illumination intensity of approximately, 40-45 mW/cm 2 corresponding to illumination times of approximately 2 min. For higher intensities ranging from 50 to 90 mW/cm 2 , no statistically significant stiffness increase could be achieved.

Conversely, Hafezi and coworkers (III Joint International Congress Refractive. On-line and SICSSO; Siena, Italy, 27-29 June 2013) reported on a more linear decrease of the corneal stiffening effect with increasing intensity leading to a reduced effect at about 18 mW/cm 2 and no significant stiffening increase at 30 mW/cm 2 and more. Such biomechanical measurements are in accordance with observations on collagen density using second harmonic imaging techniques.

The most interesting finding of this study is the failure of the Bunsen-Roscoe reciprocity law for short illumination time and high intensities. The Bunsen-Roscoe law describes the photoresponse of a material to a certain energy dose. It concludes that all photochemical reaction mechanisms depend only on the total absorbed energy and are statistically independent of the two factors that determine total absorbed energy-that is, radiant intensity or irradiance, and exposure time. A review of the validity of the Bunsen-Roscoe law in biology and medicine shows that approximately 95% and over 80%, respectively, of the evaluated reactions follow the law of reciprocity. The failure of the law observed in this study is probably due to the relative complex photochemistry that is not fully understood at this time.

On the basis of the known chemical reactions and diffusion rates of riboflavin and oxygen into the cornea, some authors [4] developed a theoretical model consistent with corneal oxygen consumption experimental results during UV-A irradiation under different conditions. Oxygen concentration in the cornea is modulated by UV-A irradiance and temperature and quickly decreased at the beginning of UV-A exposure. The time-dependence of both type-I and type-II photochemical mechanisms in corneal cross-linking with riboflavin are considered. Based on their chemical kinetics modeling approach, the authors suggested that the main photochemical kinetics mechanism is the direct interaction between riboflavin triplets and reactive groups of corneal proteins, which leads to the cross-linking of the proteins mainly through radical reactions (Type I) and not mainly driven Type II mechanism where the excited sensitizer reacts with oxygen to form singlet molecular oxygen.

Recently presented in vitro data presented by Hafezi and co-workers (III Joint International Congress Refractive On-line and SICSSO; Siena, Italy, 27-29 June 2013), however, are not in alignment with model findings of Kamaev et al.[4] Hafezi and co-workers reported about a complete failure of cross-linking, if pig corneas are placed in an atmosphere without oxygen in the air during the CXL treatment. An explanation for their findings might be that the higher intensities might be the quick consumption of oxygen within the cornea during the first seconds of the UV light illumination, but no effect from the Type I reactions. In case of higher intensity, the oxygen consumption rate is faster and new oxygen is not able to diffuse into the stroma during the treatment time as the diffusion of oxygen is a slow process and can take a couple of minutes. This, might also explain why higher intensity (>10 mW/cm 2 ) demonstrate either a reduced or no stiffening effect.

The clinical benefits of increasing the intensity and reducing the treatment time are still unknown. Based on the in vitro results, one might expect a reduced efficacy when using short treatment times. Some authors report on the use of 40 mW/cm 2 for only 45 s (1.8 J/cm 2 ) in combination with LASIK procedures to prevent patients from iatrogenic ectasia. However, such small energy doses where found to be insufficient to increase corneal stiffening in vitro. [5],[6] As iatrogenic ectasias are known to be a seldom complications, a clinical trial to demonstrate efficacy of corneal cross-linking to prevent iatrogenic ectasia are somewhat not practical as they would require very large study cohorts. On the other hand, cross-linking might provide a better refractive predictability after a LASIK procedure. Kanellopolous has reported during the 8 th International Conference on Corneal Cross Linking in Geneva, Switzerland that the introduction of corneal cross linking has led to an improved refractive predictability after hyperopic LASIK. These findings are somewhat contrary to the reported influence of the corneal epithelium hyperplasia after hyperopic LASIK. [7] Until today we are still lacking a prospective clinical proof of concept for the use of corneal cross linking in combination with LASIK procedures.

In conclusion, there is good experimental evidence that higher intensities of more than 10 mW/cm 2 have a reduced biomechanical effect compared to the standard protocol (3 mW/cm 2 for 30 min). A reason for this might be the oxygen consumption and the failure of Type I photochemical reactions. As a clinical consequence, a reduction of the treatment time by simply increasing the intensity might not lead to the same efficacy of stopping the progression of corneal ectasia and might lead to higher failure rates. Application of corneal cross linking in corneal laser surgery can still be considered as experimental and is lacking clinical trials to demonstrate efficacy.

  References Top

Iovieno A, Oechsler RA, Yoo SH. Long-term results of collagen crosslinking with riboflavin and UVA in keratoconus. J Cataract Refract Surg 2008;34:1616-7.  Back to cited text no. 1
Schumacher S, Oeftiger L, Mrochen M. Equivalence of biomechanical changes induced by rapid and standard corneal cross-linking, using riboflavin and ultraviolet radiation. Invest Ophthalmol Vis Sci 2011;52:9048-52.  Back to cited text no. 2
Wernli J, Schumacher S, Spoerl E, Mrochen M. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci 2013;54:1176-80.  Back to cited text no. 3
Kamaev P, Friedman MD, Sherr E, Muller D. Photochemical kinetics of corneal cross-linking with riboflavin. Invest Ophthalmol Vis Sci 2012;53:2360-7.  Back to cited text no. 4
Spoerl E, Huhle M, Kasper M, Seiler T. Increased rigidity of the cornea caused by intrastroaml cross-linking. Ophthalmologe 1997;94:902-6.  Back to cited text no. 5
Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 2003;29:1780-5.  Back to cited text no. 6
Reinstein DZ, Silverman RH, Raevsky T, Simoni GJ, Lloyd HO, Najafi DJ, et al. Arc-scanning very high-frequency digital ultrasound for 3D pachymetric mapping of the corneal epithelium and stroma in laser in situ keratomileusis. J Refract Surg 2000;16:414-30.  Back to cited text no. 7

This article has been cited by
1 Comparison of accelerated corneal cross-linking for progressive keratoconus in pediatric and adult age groups: One-year results
M. Berhuni, C. Ozturkmen
Journal Français d'Ophtalmologie. 2022;
[Pubmed] | [DOI]
2 Corneal cross-linking approaches on keratoconus treatment
Eren Aytekin, Sibel Bozdag Pehlivan
Journal of Drug Delivery Science and Technology. 2021; 63: 102524
[Pubmed] | [DOI]

Long-Term Visual, Refractive and Topographic Outcomes of “Epi-off” Corneal Collagen Cross-Linking in Pediatric Keratoconus: Standard versus Accelerated Protocol

Ibrahim Amer, Abdelhakeem Elaskary, Ali Mostafa, Hazem A Hazem, Ahmed Omar, Ahmed Abdou
Clinical Ophthalmology. 2020; Volume 14: 3747
[Pubmed] | [DOI]
4 Conventional vs. pulsed-light accelerated corneal collagen cross-linking for the treatment of progressive keratoconus: 12-month results from a prospective study
Liang-Zhu Jiang, Wei Jiang, Shi-Yan Qiu
Experimental and Therapeutic Medicine. 2017;
[Pubmed] | [DOI]
5 An Algorithm to Predict the Biomechanical Stiffening Effect in Corneal Cross-linking
Sabine Kling, Farhad Hafezi
Journal of Refractive Surgery. 2017; 33(2): 128
[Pubmed] | [DOI]
6 Current review and a simplified "five-point management algorithm" for keratoconus
Rohit Shetty, Luci Kaweri, Natasha Pahuja, Harsha Nagaraja, Kareeshma Wadia, Chaitra Jayadev, Rudy Nuijts, Vishal Arora
Indian Journal of Ophthalmology. 2015; 63(1): 46
[Pubmed] | [DOI]
7 Safety profile of accelerated corneal cross-linking versus conventional cross-linking: a comparative study on ex vivo-cultured limbal epithelial cells
R. Shetty,H. Matalia,R. Nuijts,M. Subramani,K. Dhamodaran,R. Pandian,C. Jayadev,D. Das
British Journal of Ophthalmology. 2015; 99(2): 272
[Pubmed] | [DOI]
8 Two-Year Accelerated Corneal Cross-Linking Outcome in Patients with Progressive Keratoconus
Arleta Waszczykowska,Piotr Jurowski
BioMed Research International. 2015; 2015: 1
[Pubmed] | [DOI]
9 Intraoperative Optical Coherence Tomography Using the RESCAN 700: Preliminary Results in Collagen Crosslinking
Natasha Pahuja,Rohit Shetty,Chaitra Jayadev,Rudy Nuijts,Bharath Hedge,Vishal Arora
BioMed Research International. 2015; 2015: 1
[Pubmed] | [DOI]
10 Accelerated Corneal Collagen Cross-Linking in Pediatric Patients: Two-Year Follow-Up Results
Rohit Shetty,Harsha Nagaraja,Chaitra Jayadev,Natasha Kishore Pahuja,Mathew Kurian Kummelil,Rudy M. M. A. Nuijts
BioMed Research International. 2014; 2014: 1
[Pubmed] | [DOI]
11 Evaluation of Corneal Stromal Demarcation Line after Two Different Protocols of Accelerated Corneal Collagen Cross-Linking Procedures Using Anterior Segment Optical Coherence Tomography and Confocal Microscopy
Engin Bilge Ozgurhan,Betul Ilkay Sezgin Akcay,Yusuf Yildirim,Gonul Karatas,Tugba Kurt,Ahmet Demirok
Journal of Ophthalmology. 2014; 2014: 1
[Pubmed] | [DOI]
12 Isotonic Riboflavin and HPMC With Accelerated Cross-Linking Protocol
Vandana Jain,Zarine Gazali,Rohan Bidayi
Cornea. 2014; 33(9): 910
[Pubmed] | [DOI]
13 Safety evaluation of rabbit eyes on scleral collagen cross-linking by riboflavin and ultraviolet A
Mengmeng Wang,Fengju Zhang,Kegao Liu,Xu Zhao
Clinical & Experimental Ophthalmology. 2014; : n/a
[Pubmed] | [DOI]
14 Evaluation of Corneal Changes After Conventional Versus Accelerated Corneal Cross-linking: A Randomized Controlled Trial
Hesam Hashemian,Mahmoud Jabbarvand,Mehdi Khodaparast,Kambiz Ameli
Journal of Refractive Surgery. 2014; 30(12): 837
[Pubmed] | [DOI]
15 An Overview of Corneal Collagen Cross-Linking (CXL)
George D. Kymionis,Dimitrios G. Mikropoulos,Dimitra M. Portaliou,Irini C. Voudouragkaki,Vassilios P. Kozobolis,Anastasios G. P. Konstas
Advances in Therapy. 2013; 30(10): 858
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded522    
    Comments [Add]    
    Cited by others 15    

Recommend this journal